Global Health Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Global Health Limited (Medanta) has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2025. The certificate, issued by the company's Registrar and Transfer Agent (Kfin Technologies Limited), was filed separately with both CDSL and NSDL. It confirms that no securities of the company were dematerialized or rematerialized during the quarter, meaning no shares were converted between physical and demat form. As there were no such transactions, no further intimation to depositories or stock exchanges was required. The filing was signed by Rahul Ranjan, Company Secretary, on July 9, 2025.
This is a routine, procedural regulatory filing with no material impact on the business, stock price, or shareholders. It simply confirms that there was no physical-to-demat (or vice versa) share movement activity during the quarter.